Chatbots are far more predictable in their responses than you might expect. That's fine for research or coding, but it's a ...

AI-native development is changing how engineering teams create value. Here's why traditional productivity frameworks are no ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Nuance and Judgement are Needed for an AI Resilient Enterprise. While multi-modal AI can ingest vast amounts of data, it ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

Abstract: Parameter identification plays an important role in ensuring the stability and efficiency of the system. In this paper, a parameter identification algorithm for robots using brushless DC ...

And what leaders can do to ease the anxiety. by Erik Hermann, Stefano Puntoni and Carey K. Morewedge As gen AI takes over tasks that were once considered uniquely human, workers are starting to ...

The Insider is a weekly, subscriber-only newsletter, where our managing editor curates HBR stories, research, and ideas that senior leaders shouldn’t miss. Harvard ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks with Huge Upside Potential. On May 14, Morgan Stanley raised the price target on Recursion Pharmaceuticals, Inc.